0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Biopharmaceutical Transport - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-21H5809
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biopharmaceutical Transport Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Biopharmaceutical Transport - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-21H5809
Report
October 2024
Pages:131
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Biopharmaceutical Transport - Market Size

The global market for Biopharmaceutical Transport was estimated to be worth US$ 89320 million in 2023 and is forecast to a readjusted size of US$ 125680 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030

Biopharmaceutical Transport - Market

Biopharmaceutical Transport - Market

Biopharmaceutical Logistics is the logistics of Biopharmaceutical, medical and surgical supplies, and other products needed to support doctors, nurses, and other health and dental care providers.
The Biopharmaceutical Transport market is primarily driven by the rapid growth of the biopharmaceutical industry, which includes the production and distribution of biologic drugs, vaccines, and other complex biopharmaceutical products. These products often require specialized transportation and handling due to their sensitivity to temperature variations and the need for maintaining product integrity. The increasing demand for personalized medicine, cell therapies, and advanced treatments further fuels the need for reliable and efficient biopharmaceutical transport solutions. However, this market also faces challenges such as stringent regulatory requirements, complex logistics networks, and the need to maintain a consistent cold chain to ensure the stability and efficacy of biopharmaceutical products during transit. Innovations in temperature-controlled packaging, monitoring technologies, and streamlined logistics processes are crucial to addressing these challenges and ensuring the safe and timely delivery of biopharmaceuticals to patients worldwide.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical Transport, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Biopharmaceutical Transport by region & country, by Type, and by Application.
The Biopharmaceutical Transport market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical Transport.
Market Segmentation

Scope of Biopharmaceutical Transport - Market Report

Report Metric Details
Report Name Biopharmaceutical Transport - Market
Forecasted market size in 2030 US$ 125680 million
CAGR 5.0%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
  • Ground Shipping
  • Sea Shipping
  • Air Shipping
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Deutsche Post DHL, Kuehne + Nagel, FedEx, AmerisourceBergen, UPS (Marken), DB Schenker, XPO Logistics, Panalpina, Nippon Express, GEODIS, VersaCold, Agility, DSV, Sinotrans, Kerry Logistics, SF Express, CEVA, CH Robinson, Air Canada Cargo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Biopharmaceutical Transport manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Biopharmaceutical Transport in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Biopharmaceutical Transport in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Biopharmaceutical Transport - Market size in 2030?

Ans: The Biopharmaceutical Transport - Market size in 2030 will be US$ 125680 million.

Who are the main players in the Biopharmaceutical Transport - Market report?

Ans: The main players in the Biopharmaceutical Transport - Market are Deutsche Post DHL, Kuehne + Nagel, FedEx, AmerisourceBergen, UPS (Marken), DB Schenker, XPO Logistics, Panalpina, Nippon Express, GEODIS, VersaCold, Agility, DSV, Sinotrans, Kerry Logistics, SF Express, CEVA, CH Robinson, Air Canada Cargo

What are the Application segmentation covered in the Biopharmaceutical Transport - Market report?

Ans: The Applications covered in the Biopharmaceutical Transport - Market report are Ground Shipping, Sea Shipping, Air Shipping

What are the Type segmentation covered in the Biopharmaceutical Transport - Market report?

Ans: The Types covered in the Biopharmaceutical Transport - Market report are Cold Chain Transport, Non-cold Chain Transport

Recommended Reports

Biopharmaceutical Logistics

Biopharma Devices & Packaging

Biopharma Manufacturing

1 Market Overview
1.1 Biopharmaceutical Transport Product Introduction
1.2 Global Biopharmaceutical Transport Market Size Forecast
1.3 Biopharmaceutical Transport Market Trends & Drivers
1.3.1 Biopharmaceutical Transport Industry Trends
1.3.2 Biopharmaceutical Transport Market Drivers & Opportunity
1.3.3 Biopharmaceutical Transport Market Challenges
1.3.4 Biopharmaceutical Transport Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Biopharmaceutical Transport Players Revenue Ranking (2023)
2.2 Global Biopharmaceutical Transport Revenue by Company (2019-2024)
2.3 Key Companies Biopharmaceutical Transport Manufacturing Base Distribution and Headquarters
2.4 Key Companies Biopharmaceutical Transport Product Offered
2.5 Key Companies Time to Begin Mass Production of Biopharmaceutical Transport
2.6 Biopharmaceutical Transport Market Competitive Analysis
2.6.1 Biopharmaceutical Transport Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Biopharmaceutical Transport Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Transport as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Cold Chain Transport
3.1.2 Non-cold Chain Transport
3.2 Global Biopharmaceutical Transport Sales Value by Type
3.2.1 Global Biopharmaceutical Transport Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Biopharmaceutical Transport Sales Value, by Type (2019-2030)
3.2.3 Global Biopharmaceutical Transport Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Ground Shipping
4.1.2 Sea Shipping
4.1.3 Air Shipping
4.2 Global Biopharmaceutical Transport Sales Value by Application
4.2.1 Global Biopharmaceutical Transport Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Biopharmaceutical Transport Sales Value, by Application (2019-2030)
4.2.3 Global Biopharmaceutical Transport Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Biopharmaceutical Transport Sales Value by Region
5.1.1 Global Biopharmaceutical Transport Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Biopharmaceutical Transport Sales Value by Region (2019-2024)
5.1.3 Global Biopharmaceutical Transport Sales Value by Region (2025-2030)
5.1.4 Global Biopharmaceutical Transport Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Biopharmaceutical Transport Sales Value, 2019-2030
5.2.2 North America Biopharmaceutical Transport Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Biopharmaceutical Transport Sales Value, 2019-2030
5.3.2 Europe Biopharmaceutical Transport Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Biopharmaceutical Transport Sales Value, 2019-2030
5.4.2 Asia Pacific Biopharmaceutical Transport Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Biopharmaceutical Transport Sales Value, 2019-2030
5.5.2 South America Biopharmaceutical Transport Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Biopharmaceutical Transport Sales Value, 2019-2030
5.6.2 Middle East & Africa Biopharmaceutical Transport Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Biopharmaceutical Transport Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Biopharmaceutical Transport Sales Value
6.3 United States
6.3.1 United States Biopharmaceutical Transport Sales Value, 2019-2030
6.3.2 United States Biopharmaceutical Transport Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Biopharmaceutical Transport Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Biopharmaceutical Transport Sales Value, 2019-2030
6.4.2 Europe Biopharmaceutical Transport Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Biopharmaceutical Transport Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Biopharmaceutical Transport Sales Value, 2019-2030
6.5.2 China Biopharmaceutical Transport Sales Value by Type (%), 2023 VS 2030
6.5.3 China Biopharmaceutical Transport Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Biopharmaceutical Transport Sales Value, 2019-2030
6.6.2 Japan Biopharmaceutical Transport Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Biopharmaceutical Transport Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Biopharmaceutical Transport Sales Value, 2019-2030
6.7.2 South Korea Biopharmaceutical Transport Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Biopharmaceutical Transport Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Biopharmaceutical Transport Sales Value, 2019-2030
6.8.2 Southeast Asia Biopharmaceutical Transport Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Biopharmaceutical Transport Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Biopharmaceutical Transport Sales Value, 2019-2030
6.9.2 India Biopharmaceutical Transport Sales Value by Type (%), 2023 VS 2030
6.9.3 India Biopharmaceutical Transport Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Deutsche Post DHL
7.1.1 Deutsche Post DHL Profile
7.1.2 Deutsche Post DHL Main Business
7.1.3 Deutsche Post DHL Biopharmaceutical Transport Products, Services and Solutions
7.1.4 Deutsche Post DHL Biopharmaceutical Transport Revenue (US$ Million) & (2019-2024)
7.1.5 Deutsche Post DHL Recent Developments
7.2 Kuehne + Nagel
7.2.1 Kuehne + Nagel Profile
7.2.2 Kuehne + Nagel Main Business
7.2.3 Kuehne + Nagel Biopharmaceutical Transport Products, Services and Solutions
7.2.4 Kuehne + Nagel Biopharmaceutical Transport Revenue (US$ Million) & (2019-2024)
7.2.5 Kuehne + Nagel Recent Developments
7.3 FedEx
7.3.1 FedEx Profile
7.3.2 FedEx Main Business
7.3.3 FedEx Biopharmaceutical Transport Products, Services and Solutions
7.3.4 FedEx Biopharmaceutical Transport Revenue (US$ Million) & (2019-2024)
7.3.5 AmerisourceBergen Recent Developments
7.4 AmerisourceBergen
7.4.1 AmerisourceBergen Profile
7.4.2 AmerisourceBergen Main Business
7.4.3 AmerisourceBergen Biopharmaceutical Transport Products, Services and Solutions
7.4.4 AmerisourceBergen Biopharmaceutical Transport Revenue (US$ Million) & (2019-2024)
7.4.5 AmerisourceBergen Recent Developments
7.5 UPS (Marken)
7.5.1 UPS (Marken) Profile
7.5.2 UPS (Marken) Main Business
7.5.3 UPS (Marken) Biopharmaceutical Transport Products, Services and Solutions
7.5.4 UPS (Marken) Biopharmaceutical Transport Revenue (US$ Million) & (2019-2024)
7.5.5 UPS (Marken) Recent Developments
7.6 DB Schenker
7.6.1 DB Schenker Profile
7.6.2 DB Schenker Main Business
7.6.3 DB Schenker Biopharmaceutical Transport Products, Services and Solutions
7.6.4 DB Schenker Biopharmaceutical Transport Revenue (US$ Million) & (2019-2024)
7.6.5 DB Schenker Recent Developments
7.7 XPO Logistics
7.7.1 XPO Logistics Profile
7.7.2 XPO Logistics Main Business
7.7.3 XPO Logistics Biopharmaceutical Transport Products, Services and Solutions
7.7.4 XPO Logistics Biopharmaceutical Transport Revenue (US$ Million) & (2019-2024)
7.7.5 XPO Logistics Recent Developments
7.8 Panalpina
7.8.1 Panalpina Profile
7.8.2 Panalpina Main Business
7.8.3 Panalpina Biopharmaceutical Transport Products, Services and Solutions
7.8.4 Panalpina Biopharmaceutical Transport Revenue (US$ Million) & (2019-2024)
7.8.5 Panalpina Recent Developments
7.9 Nippon Express
7.9.1 Nippon Express Profile
7.9.2 Nippon Express Main Business
7.9.3 Nippon Express Biopharmaceutical Transport Products, Services and Solutions
7.9.4 Nippon Express Biopharmaceutical Transport Revenue (US$ Million) & (2019-2024)
7.9.5 Nippon Express Recent Developments
7.10 GEODIS
7.10.1 GEODIS Profile
7.10.2 GEODIS Main Business
7.10.3 GEODIS Biopharmaceutical Transport Products, Services and Solutions
7.10.4 GEODIS Biopharmaceutical Transport Revenue (US$ Million) & (2019-2024)
7.10.5 GEODIS Recent Developments
7.11 VersaCold
7.11.1 VersaCold Profile
7.11.2 VersaCold Main Business
7.11.3 VersaCold Biopharmaceutical Transport Products, Services and Solutions
7.11.4 VersaCold Biopharmaceutical Transport Revenue (US$ Million) & (2019-2024)
7.11.5 VersaCold Recent Developments
7.12 Agility
7.12.1 Agility Profile
7.12.2 Agility Main Business
7.12.3 Agility Biopharmaceutical Transport Products, Services and Solutions
7.12.4 Agility Biopharmaceutical Transport Revenue (US$ Million) & (2019-2024)
7.12.5 Agility Recent Developments
7.13 DSV
7.13.1 DSV Profile
7.13.2 DSV Main Business
7.13.3 DSV Biopharmaceutical Transport Products, Services and Solutions
7.13.4 DSV Biopharmaceutical Transport Revenue (US$ Million) & (2019-2024)
7.13.5 DSV Recent Developments
7.14 Sinotrans
7.14.1 Sinotrans Profile
7.14.2 Sinotrans Main Business
7.14.3 Sinotrans Biopharmaceutical Transport Products, Services and Solutions
7.14.4 Sinotrans Biopharmaceutical Transport Revenue (US$ Million) & (2019-2024)
7.14.5 Sinotrans Recent Developments
7.15 Kerry Logistics
7.15.1 Kerry Logistics Profile
7.15.2 Kerry Logistics Main Business
7.15.3 Kerry Logistics Biopharmaceutical Transport Products, Services and Solutions
7.15.4 Kerry Logistics Biopharmaceutical Transport Revenue (US$ Million) & (2019-2024)
7.15.5 Kerry Logistics Recent Developments
7.16 SF Express
7.16.1 SF Express Profile
7.16.2 SF Express Main Business
7.16.3 SF Express Biopharmaceutical Transport Products, Services and Solutions
7.16.4 SF Express Biopharmaceutical Transport Revenue (US$ Million) & (2019-2024)
7.16.5 SF Express Recent Developments
7.17 CEVA
7.17.1 CEVA Profile
7.17.2 CEVA Main Business
7.17.3 CEVA Biopharmaceutical Transport Products, Services and Solutions
7.17.4 CEVA Biopharmaceutical Transport Revenue (US$ Million) & (2019-2024)
7.17.5 CEVA Recent Developments
7.18 CH Robinson
7.18.1 CH Robinson Profile
7.18.2 CH Robinson Main Business
7.18.3 CH Robinson Biopharmaceutical Transport Products, Services and Solutions
7.18.4 CH Robinson Biopharmaceutical Transport Revenue (US$ Million) & (2019-2024)
7.18.5 CH Robinson Recent Developments
7.19 Air Canada Cargo
7.19.1 Air Canada Cargo Profile
7.19.2 Air Canada Cargo Main Business
7.19.3 Air Canada Cargo Biopharmaceutical Transport Products, Services and Solutions
7.19.4 Air Canada Cargo Biopharmaceutical Transport Revenue (US$ Million) & (2019-2024)
7.19.5 Air Canada Cargo Recent Developments
8 Industry Chain Analysis
8.1 Biopharmaceutical Transport Industrial Chain
8.2 Biopharmaceutical Transport Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Biopharmaceutical Transport Sales Model
8.5.2 Sales Channel
8.5.3 Biopharmaceutical Transport Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Biopharmaceutical Transport Market Trends
    Table 2. Biopharmaceutical Transport Market Drivers & Opportunity
    Table 3. Biopharmaceutical Transport Market Challenges
    Table 4. Biopharmaceutical Transport Market Restraints
    Table 5. Global Biopharmaceutical Transport Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Biopharmaceutical Transport Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Biopharmaceutical Transport Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Biopharmaceutical Transport Product Type
    Table 9. Key Companies Time to Begin Mass Production of Biopharmaceutical Transport
    Table 10. Global Biopharmaceutical Transport Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Transport as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Biopharmaceutical Transport Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Biopharmaceutical Transport Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Biopharmaceutical Transport Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Biopharmaceutical Transport Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Biopharmaceutical Transport Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Biopharmaceutical Transport Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Biopharmaceutical Transport Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Biopharmaceutical Transport Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Biopharmaceutical Transport Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Biopharmaceutical Transport Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Biopharmaceutical Transport Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Biopharmaceutical Transport Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Biopharmaceutical Transport Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Biopharmaceutical Transport Sales Value by Region (2019-2024) & (%)
    Table 27. Global Biopharmaceutical Transport Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Biopharmaceutical Transport Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Biopharmaceutical Transport Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Biopharmaceutical Transport Sales Value, (2025-2030) & (US$ Million)
    Table 31. Deutsche Post DHL Basic Information List
    Table 32. Deutsche Post DHL Description and Business Overview
    Table 33. Deutsche Post DHL Biopharmaceutical Transport Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Biopharmaceutical Transport Business of Deutsche Post DHL (2019-2024)
    Table 35. Deutsche Post DHL Recent Developments
    Table 36. Kuehne + Nagel Basic Information List
    Table 37. Kuehne + Nagel Description and Business Overview
    Table 38. Kuehne + Nagel Biopharmaceutical Transport Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Biopharmaceutical Transport Business of Kuehne + Nagel (2019-2024)
    Table 40. Kuehne + Nagel Recent Developments
    Table 41. FedEx Basic Information List
    Table 42. FedEx Description and Business Overview
    Table 43. FedEx Biopharmaceutical Transport Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Biopharmaceutical Transport Business of FedEx (2019-2024)
    Table 45. FedEx Recent Developments
    Table 46. AmerisourceBergen Basic Information List
    Table 47. AmerisourceBergen Description and Business Overview
    Table 48. AmerisourceBergen Biopharmaceutical Transport Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Biopharmaceutical Transport Business of AmerisourceBergen (2019-2024)
    Table 50. AmerisourceBergen Recent Developments
    Table 51. UPS (Marken) Basic Information List
    Table 52. UPS (Marken) Description and Business Overview
    Table 53. UPS (Marken) Biopharmaceutical Transport Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Biopharmaceutical Transport Business of UPS (Marken) (2019-2024)
    Table 55. UPS (Marken) Recent Developments
    Table 56. DB Schenker Basic Information List
    Table 57. DB Schenker Description and Business Overview
    Table 58. DB Schenker Biopharmaceutical Transport Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Biopharmaceutical Transport Business of DB Schenker (2019-2024)
    Table 60. DB Schenker Recent Developments
    Table 61. XPO Logistics Basic Information List
    Table 62. XPO Logistics Description and Business Overview
    Table 63. XPO Logistics Biopharmaceutical Transport Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Biopharmaceutical Transport Business of XPO Logistics (2019-2024)
    Table 65. XPO Logistics Recent Developments
    Table 66. Panalpina Basic Information List
    Table 67. Panalpina Description and Business Overview
    Table 68. Panalpina Biopharmaceutical Transport Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Biopharmaceutical Transport Business of Panalpina (2019-2024)
    Table 70. Panalpina Recent Developments
    Table 71. Nippon Express Basic Information List
    Table 72. Nippon Express Description and Business Overview
    Table 73. Nippon Express Biopharmaceutical Transport Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Biopharmaceutical Transport Business of Nippon Express (2019-2024)
    Table 75. Nippon Express Recent Developments
    Table 76. GEODIS Basic Information List
    Table 77. GEODIS Description and Business Overview
    Table 78. GEODIS Biopharmaceutical Transport Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Biopharmaceutical Transport Business of GEODIS (2019-2024)
    Table 80. GEODIS Recent Developments
    Table 81. VersaCold Basic Information List
    Table 82. VersaCold Description and Business Overview
    Table 83. VersaCold Biopharmaceutical Transport Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Biopharmaceutical Transport Business of VersaCold (2019-2024)
    Table 85. VersaCold Recent Developments
    Table 86. Agility Basic Information List
    Table 87. Agility Description and Business Overview
    Table 88. Agility Biopharmaceutical Transport Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Biopharmaceutical Transport Business of Agility (2019-2024)
    Table 90. Agility Recent Developments
    Table 91. DSV Basic Information List
    Table 92. DSV Description and Business Overview
    Table 93. DSV Biopharmaceutical Transport Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Biopharmaceutical Transport Business of DSV (2019-2024)
    Table 95. DSV Recent Developments
    Table 96. Sinotrans Basic Information List
    Table 97. Sinotrans Description and Business Overview
    Table 98. Sinotrans Biopharmaceutical Transport Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Biopharmaceutical Transport Business of Sinotrans (2019-2024)
    Table 100. Sinotrans Recent Developments
    Table 101. Kerry Logistics Basic Information List
    Table 102. Kerry Logistics Description and Business Overview
    Table 103. Kerry Logistics Biopharmaceutical Transport Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Biopharmaceutical Transport Business of Kerry Logistics (2019-2024)
    Table 105. Kerry Logistics Recent Developments
    Table 106. SF Express Basic Information List
    Table 107. SF Express Description and Business Overview
    Table 108. SF Express Biopharmaceutical Transport Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Biopharmaceutical Transport Business of SF Express (2019-2024)
    Table 110. SF Express Recent Developments
    Table 111. CEVA Basic Information List
    Table 112. CEVA Description and Business Overview
    Table 113. CEVA Biopharmaceutical Transport Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Biopharmaceutical Transport Business of CEVA (2019-2024)
    Table 115. CEVA Recent Developments
    Table 116. CH Robinson Basic Information List
    Table 117. CH Robinson Description and Business Overview
    Table 118. CH Robinson Biopharmaceutical Transport Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Biopharmaceutical Transport Business of CH Robinson (2019-2024)
    Table 120. CH Robinson Recent Developments
    Table 121. Air Canada Cargo Basic Information List
    Table 122. Air Canada Cargo Description and Business Overview
    Table 123. Air Canada Cargo Biopharmaceutical Transport Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Biopharmaceutical Transport Business of Air Canada Cargo (2019-2024)
    Table 125. Air Canada Cargo Recent Developments
    Table 126. Key Raw Materials Lists
    Table 127. Raw Materials Key Suppliers Lists
    Table 128. Biopharmaceutical Transport Downstream Customers
    Table 129. Biopharmaceutical Transport Distributors List
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
    Table 133. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Biopharmaceutical Transport Product Picture
    Figure 2. Global Biopharmaceutical Transport Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Biopharmaceutical Transport Sales Value (2019-2030) & (US$ Million)
    Figure 4. Biopharmaceutical Transport Report Years Considered
    Figure 5. Global Biopharmaceutical Transport Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Biopharmaceutical Transport Revenue in 2023
    Figure 7. Biopharmaceutical Transport Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Cold Chain Transport Picture
    Figure 9. Non-cold Chain Transport Picture
    Figure 10. Global Biopharmaceutical Transport Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Biopharmaceutical Transport Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Ground Shipping
    Figure 13. Product Picture of Sea Shipping
    Figure 14. Product Picture of Air Shipping
    Figure 15. Global Biopharmaceutical Transport Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Biopharmaceutical Transport Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Biopharmaceutical Transport Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Biopharmaceutical Transport Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Biopharmaceutical Transport Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Biopharmaceutical Transport Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Biopharmaceutical Transport Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Biopharmaceutical Transport Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Biopharmaceutical Transport Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Biopharmaceutical Transport Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Biopharmaceutical Transport Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Biopharmaceutical Transport Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Biopharmaceutical Transport Sales Value (%), (2019-2030)
    Figure 28. United States Biopharmaceutical Transport Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Biopharmaceutical Transport Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Biopharmaceutical Transport Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Biopharmaceutical Transport Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Biopharmaceutical Transport Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Biopharmaceutical Transport Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Biopharmaceutical Transport Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Biopharmaceutical Transport Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Biopharmaceutical Transport Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Biopharmaceutical Transport Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Biopharmaceutical Transport Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Biopharmaceutical Transport Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Biopharmaceutical Transport Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Biopharmaceutical Transport Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Biopharmaceutical Transport Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Biopharmaceutical Transport Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Biopharmaceutical Transport Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Biopharmaceutical Transport Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Biopharmaceutical Transport Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Biopharmaceutical Transport Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Biopharmaceutical Transport Sales Value by Application (%), 2023 VS 2030
    Figure 49. Biopharmaceutical Transport Industrial Chain
    Figure 50. Biopharmaceutical Transport Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart